THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 123 filers reported holding THERAVANCE BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 3.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $172,906 | -66.4% | 15,936 | -65.2% | 0.00% | -66.7% |
| Q4 2022 | $514,022 | -77.6% | 45,813 | -81.9% | 0.00% | -75.0% |
| Q2 2022 | $2,291,000 | -28.5% | 252,845 | -24.5% | 0.01% | -33.3% |
| Q1 2022 | $3,204,000 | +66.6% | 335,106 | +92.5% | 0.02% | +63.6% |
| Q4 2021 | $1,923,000 | +17.6% | 174,070 | -21.2% | 0.01% | 0.0% |
| Q3 2021 | $1,635,000 | +216.9% | 220,894 | +533.0% | 0.01% | +175.0% |
| Q3 2020 | $516,000 | -59.8% | 34,899 | -42.9% | 0.00% | -73.3% |
| Q2 2020 | $1,282,000 | +70.3% | 61,091 | +109.9% | 0.02% | 0.0% |
| Q4 2019 | $753,000 | – | 29,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 452,615 | $11,718,000 | 0.12% |